Cancer Research Technology (CRT), charity Cancer Research UK’s subsidiary to commercialise academic research into oncology treatments, has set up a £50m ($80m) venture fund. CRT and the European Investment Fund (EIF), a state-backed organisation that is the largest investor – called limited partner – in European venture capital funds, will equally split the commitments for…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
